Apoptosis: from Signalling Pathways to Therapeutic Tools

Authors

  • Peter Hersey Immunology and Oncology Unit, Newcastle Mater Hospital, Newcastle, New South Wales, Australia
  • Seyed Hadi Mousavi Department of Pharmacology and Pharmacological Research Centre of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran|Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  • Zahra Tayarani-Najaran Department of Pharmacology and Pharmacological Research Centre of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:

Apoptosis or programmed cell death is a gene regulated phenomenon which is important in both physiological and pathological conditions. It is characterized by distinct morphological features including chromatin condensation, cell and nuclear shrinkage, membrane blebbing and oligonucleosomal DNA fragmentation. Although, two major apoptotic pathways including 1) the death receptor (extrinsic) and 2) mitochondrial (intrinsic) pathway have been identified, recently endoplasmic reticulum and lysosomal pathways have been also recognized. Depending on both the cell type and the initiating factor, distinct pathways are activated. The pathways share a common final phase of apoptosis, consisting of activation of the executioner caspases and dismantling of substrates critical for cell survival. The important regulatory mechanisms include death receptors, caspases, mitochondria and Bcl-2 family proteins. Modulating of apoptosis is a novel therapeutic strategy in treatment of different diseases. These include situations with unwanted cell accumulation (cancer) and failure to diminish aberrant cells (autoimmune diseases) or diseases with an inappropriate cell loss (heart failure, stroke, AIDS and neurodegenerative diseases).  Modulation of apoptosis is a novel therapeutic strategy in treatment of different diseases. Many approaches including gene therapy, antisense strategies and numerous apoptotic drugs to target specific apoptotic regulators, are currently being developed. The goal of this review is to provide a general overview of current knowledge on the process of apoptosis including morphology, biochemistry, signaling as well as a discussion of apoptosis in diseases and effective therapy.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

apoptosis: from signalling pathways to therapeutic tools

apoptosis or programmed cell death is a gene regulated phenomenon which is important in both physiological and pathological conditions. it is characterized by distinct morphological features including chromatin condensation, cell and nuclear shrinkage, membrane blebbing and oligonucleosomal dna fragmentation. although, two major apoptotic pathways including 1) the death receptor (extrinsic) and...

full text

Pathways from glutamine to apoptosis.

It is fascinating that a relatively simple amino acid like glutamine is involved in such large variety of cellular reactions. Glutamine is required for nitrogen-stimulated proliferation in many cells, but glutamine stimulates not only the growth of cells but also the expression of surface antigens, the formation of cytokines, the synthesis of heat shock proteins and many more vital events. Amon...

full text

Molecular pathways: targeting inhibitor of apoptosis proteins in cancer--from molecular mechanism to therapeutic application.

Inhibitor of apoptosis (IAP) proteins play a critical role in the control of survival and cell death by regulating key signaling events such as caspase activation and NF-κB signaling. Because aberrantly high expression of IAP proteins represents a frequent oncogenic event in human cancers, therapeutic targeting of IAP proteins is considered as a promising approach. Several small-molecule pharma...

full text

Apoptosis signalling pathways in seizure-induced neuronal death and epilepsy.

Delineating the molecular pathways underlying seizure-induced neuronal death may yield novel strategies for brain protection against prolonged or repetitive seizures. Glutamate-mediated excitotoxicity and necrosis is a primary contributing mechanism but seizures also activate programmed (apoptotic) cell death pathways. Apoptosis signalling pathways are typically initiated following perturbation...

full text

Apoptosis pathways and their therapeutic exploitation in pancreatic cancer

Resistance to apoptosis (programmed cell death) is a characteristic feature of human malignancies including pancreatic cancer, which is one of the leading causes of cancer deaths in the western world. Defects in this intrinsic cell death program can contribute to the multistep process of tumorigenesis, because too little cell death can disturb tissue homeostasis. Further, blockade of apoptosis ...

full text

Cell Signalling Pathways Leading to Novel Therapeutic Strategies in Cardiovascular Disease

1Vasoactive Peptide Group, Department of Clinical Research, University of Bern, 3004 Bern, Switzerland 2Centre for Rheumatology and Connective Tissues Diseases, Royal Free Hospital, Pond Street, London NW3 2QG, UK 3Vascular Unit, Academic Department of Surgery, Royal Free Hospital, Pond Street, London NW3 2QG, UK 4Division of Surgery & Interventional Science, University College London, Royal Fr...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 11  issue 3

pages  121- 142

publication date 2008-10-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023